Browsing by Author "Gao, Xue"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
Item A general theoretical framework to design base editors with reduced bystander effects(Springer Nature, 2021) Wang, Qian; Yang, Jie; Zhong, Zhicheng; Vanegas, Jeffrey A.; Gao, Xue; Kolomeisky, Anatoly B.; Center for Theoretical Biological PhysicsBase editors (BEs) hold great potential for medical applications of gene therapy. However, high precision base editing requires BEs that can discriminate between the target base and multiple bystander bases within a narrow active window (4 – 10 nucleotides). Here, to assist in the design of these optimized editors, we propose a discrete-state stochastic approach to build an analytical model that explicitly evaluates the probabilities of editing the target base and bystanders. Combined with all-atom molecular dynamic simulations, our model reproduces the experimental data of A3A-BE3 and its variants for targeting the “TC” motif and bystander editing. Analyzing this approach, we propose several general principles that can guide the design of BEs with a reduced bystander effect. These principles are then applied to design a series of point mutations at T218 position of A3G-BEs to further reduce its bystander editing. We verify experimentally that the new mutations provide different levels of stringency on reducing the bystander editing at different genomic loci, which is consistent with our theoretical model. Thus, our study provides a computational-aided platform to assist in the scientifically-based design of BEs with reduced bystander effects.Item Embargo Advancing Precision and Controllable Molecular Tools for Genetic Engineering and Disease Treatment(2024-04-17) Zeng, Hongzhi; Gao, Xue; Verduzco, RafaelThe emergence of programmable gene editing tools has transformed life sciences by empowering researchers to execute precise and targeted genomic alterations in living cells. The advent of the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (CRISPR-Cas) technology has greatly accelerated genome editing research and applications. However, CRISPR-Cas faces limitations due to the low efficiency of homology-directed repair after Cas nuclease- induced double-stranded DNA breaks (DSBs), which can result in unintended genomic alterations and raise safety concerns. Base editors (BEs), leveraging a catalytically impaired nuclease and a single-stranded DNA deaminase enzyme, offer a promising alternative by facilitating targeted point mutations without requiring DSBs or donor DNA templates. However, the challenge of off-target effects and the lack of temporal control over BE activity when delivered via viral vectors remain significant hurdles. My thesis describes two projects that I lead: (1) A split and inducible adenine base editor for precise in vivo base editing, and (2) Precision A3G base editors and prime editors for cystic fibrosis modeling and correction. These projects explore the underlying principles of BEs, detailing engineering strategies for achieving small-molecule-controlled base editing in vivo and outline efforts to enhance the specificity of adenine and cytosine base editors. Additionally, these projects involve viral and non-viral delivery methods for BEs, emphasizing their applications in human disease modeling, treatment, and prevention. Lastly, my projects contain applications of prime editing technology, a more versatile gene-editing tool than BE, highlighting its promise for biological research and therapeutic applications.Item Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effects(American Association for the Advancement of Science, 2020) Lee, Sangsin; Ding, Ning; Sun, Yidi; Yuan, Tanglong; Li, Jing; Yuan, Qichen; Liu, Lizhong; Yang, Jie; Wang, Qian; Kolomeisky, Anatoly B.; Hilton, Isaac B.; Zuo, Erwei; Gao, Xue; Center for Theoretical and Biological PhysicsCytosine base editors (CBEs) enable efficient cytidine-to-thymidine (C-to-T) substitutions at targeted loci without double-stranded breaks. However, current CBEs edit all Cs within their activity windows, generating undesired bystander mutations. In the most challenging circumstance, when a bystander C is adjacent to the targeted C, existing base editors fail to discriminate them and edit both Cs. To improve the precision of CBE, we identified and engineered the human APOBEC3G (A3G) deaminase; when fused to the Cas9 nickase, the resulting A3G-BEs exhibit selective editing of the second C in the 5′-CC-3′ motif in human cells. Our A3G-BEs could install a single disease-associated C-to-T substitution with high precision. The percentage of perfectly modified alleles is more than 6000-fold for disease correction and more than 600-fold for disease modeling compared with BE4max. On the basis of the two-cell embryo injection method and RNA sequencing analysis, our A3G-BEs showed minimum genome- and transcriptome-wide off-target effects, achieving high targeting fidelity.Item Structural basis for the activation of a compact CRISPR-Cas13 nuclease(Springer Nature, 2023) Deng, Xiangyu; Osikpa, Emmanuel; Yang, Jie; Oladeji, Seye J.; Smith, Jamie; Gao, Xue; Gao, YangThe CRISPR-Cas13 ribonucleases have been widely applied for RNA knockdown and transcriptional modulation owing to their high programmability and specificity. However, the large size of Cas13 effectors and their non-specific RNA cleavage upon target activation limit the adeno-associated virus based delivery of Cas13 systems for therapeutic applications. Herein, we report detailed biochemical and structural characterizations of a compact Cas13 (Cas13bt3) suitable for adeno-associated virus delivery. Distinct from many other Cas13 systems, Cas13bt3 cleaves the target and other nonspecific RNA at internal “UC” sites and is activated in a target length-dependent manner. The cryo-electron microscope structure of Cas13bt3 in a fully active state illustrates the structural basis of Cas13bt3 activation. Guided by the structure, we obtain engineered Cas13bt3 variants with minimal off-target cleavage yet maintained target cleavage activities. In conclusion, our biochemical and structural data illustrate a distinct mechanism for Cas13bt3 activation and guide the engineering of Cas13bt3 applications.Item Structural basis of the stereoselective formation of the spirooxindole ring in the biosynthesis of citrinadins(Springer Nature, 2021) Liu, Zhiwen; Zhao, Fanglong; Zhao, Boyang; Yang, Jie; Ferrara, Joseph; Sankaran, Banumathi; Venkataram Prasad, B.V.; Kundu, Biki Bapi; Phillips, George N.Jr.; Gao, Yang; Hu, Liya; Zhu, Tong; Gao, XuePrenylated indole alkaloids featuring spirooxindole rings possess a 3R or 3S carbon stereocenter, which determines the bioactivities of these compounds. Despite the stereoselective advantages of spirooxindole biosynthesis compared with those of organic synthesis, the biocatalytic mechanism for controlling the 3R or 3S-spirooxindole formation has been elusive. Here, we report an oxygenase/semipinacolase CtdE that specifies the 3S-spirooxindole construction in the biosynthesis of 21R-citrinadin A. High-resolution X-ray crystal structures of CtdE with the substrate and cofactor, together with site-directed mutagenesis and computational studies, illustrate the catalytic mechanisms for the possible β-face epoxidation followed by a regioselective collapse of the epoxide intermediate, which triggers semipinacol rearrangement to form the 3S-spirooxindole. Comparing CtdE with PhqK, which catalyzes the formation of the 3R-spirooxindole, we reveal an evolutionary branch of CtdE in specific 3S spirocyclization. Our study provides deeper insights into the stereoselective catalytic machinery, which is important for the biocatalysis design to synthesize spirooxindole pharmaceuticals.